Guided immunotherapy for residual solid tumor: integrating platelets and CAR T cells to reduce post-surgical recurrence.

Heydari F, Zendehdel H, Varkiani MM, Fahmi S, Derakhshani M, Anvari S, Farhid F, Hamblin MR, Naghinezhad J

Open source

DOI
10.1186/s40364-026-00957-5
Published
2026 Jul 3
Container
Biomarker research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40364-026-00957-5,
  title = {Guided immunotherapy for residual solid tumor: integrating platelets and CAR T cells to reduce post-surgical recurrence.},
  author = {Heydari F and Zendehdel H and Varkiani MM and Fahmi S and Derakhshani M and Anvari S and Farhid F and Hamblin MR and Naghinezhad J},
  year = {2026},
  journal = {Biomarker research},
  doi = {10.1186/s40364-026-00957-5},
  url = {https://doi.org/10.1186/s40364-026-00957-5}
}

RIS

TY  - JOUR
TI  - Guided immunotherapy for residual solid tumor: integrating platelets and CAR T cells to reduce post-surgical recurrence.
AU  - Heydari F
AU  - Zendehdel H
AU  - Varkiani MM
AU  - Fahmi S
AU  - Derakhshani M
AU  - Anvari S
AU  - Farhid F
AU  - Hamblin MR
AU  - Naghinezhad J
PY  - 2026
JO  - Biomarker research
DO  - 10.1186/s40364-026-00957-5
UR  - https://doi.org/10.1186/s40364-026-00957-5
ER  - 

APA

F, H., H, Z., MM, V., S, F., M, D., S, A., F, F., MR, H., & J, N. (2026). Guided immunotherapy for residual solid tumor: integrating platelets and CAR T cells to reduce post-surgical recurrence.. Biomarker research. https://doi.org/10.1186/s40364-026-00957-5

Source records